300642.SZ

Tellgen Corporation

HealthcareMedical - DevicesCNCNYPeers →Country macro →

$13.41

Jun 05, 2026

AI Brief

Market cap

$2.18B

52w range

—

P / E

—

EPS

—

Volume

—

Revenue · FY

—

Overview Profile Ratios Multiples Themes Earnings Prices Sentiment ESG

Explain this page

Arphra AIPlain-English read on Tellgen Corporation’s valuation

Business description

· company · SEC profile

Tellgen Corporation

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally. It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems. The company was founded in 2003 and is based in Shanghai, China.

Founded

—

IPO

Apr 21, 2017

Employees

522

Shanghai

CEO

Jian Er Yao

CFO

—

Exchange

SHZ

Fiscal year

—

Identifiers

· company_identifiers

CIK

CUSIP—

ISINCNE100002P42

FIGI300642 CS

LEI—